Takeda: Gout trials
The registry lists 10 Gout studies with Takeda as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 2 3Phase 3 6No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With GoutCompletedNCT02139046Phase 3Results posted
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentCompletedNCT02128490Phase 2Results posted
- MPC-004 for the Treatment of an Acute Gout FlareCompletedNCT00506883Phase 3Results posted
- Efficacy and Safety of Oral Febuxostat in Participants With GoutCompletedNCT00430248Phase 3Results posted
- Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010CompletedNCT00175019Phase 3Results posted
- Validation Study of Physical Measurement of TophiCompletedNCT00175006Results posted
- Dose-Response, Safety and Efficacy of Febuxostat in Subjects With GoutCompletedNCT00174967Phase 2Results posted
- Long-Term Safety of Febuxostat in Subjects With Gout.CompletedNCT00174941Phase 2Results posted
- Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.CompletedNCT00174915Phase 3Results posted
- Febuxostat Versus Allopurinol Control Trial in Subjects With GoutCompletedNCT00102440Phase 3Results posted